BioScrip (BIOS) Q2 2012 Earnings Call August 09, 2012 9:00 am ET Executives Lisa Wilson Richard M. Smith - Chief Executive Officer, President, Chief Operating Officer and Director Hai V. Tran - Chief Financial Officer, Senior Vice President and Treasurer Analysts Brooks G. O'Neil - Dougherty & Company LLC, Research Division Michael John Petusky - Noble Financial Group, Inc., Research Division PresentationOperator
Ladies and gentlemen, thank you for standing by. Welcome to the BioScrip Second Quarter Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded, Thursday, August 9, 2012. I would now like to turn the conference over to Lisa Wilson, Investor Relations with BioScrip. Please go ahead Lisa Wilson Good morning, and thank you for joining us today. By now you should have received a copy of our press release issued yesterday after the close of market. If you've not received it, you may access it through the Investor Relations section at our website. Rick Smith, President and Chief Executive Officer and Hai Tran, Chief Financial Officer, will host this morning's call. The call may be accessed through our website at bioscrip.com. A replay will be available shortly after the call's completion. Interested parties can access the replay by dialing (800) 633-8284 in the U.S. and (402) 977-9140 internationally and entering access code 21600696. An audio webcast will also be available for 30 days following the call under the Investor Relations section of the BioScrip website at bioscrip.com. Before we get started, I would like to remind everyone that any forward-looking statements made during the call are protected under the Safe Harbor of the Private Securities Litigation and Reform Act. Such forward-looking statements are based upon current expectations, and there can be no assurance that the results contemplated in these statements will be realized. Actual results may differ materially from such statements due to a number of important factors and risks, which are identified in our press release and our annual and quarterly reports filed with the SEC. These forward-looking statements are based on information available to BioScrip today, and the company assumes no obligation to update statements as circumstance change.